Physician profile
David A Dowell
NPI 1841221413
$1,148.36
in general payments reported to CMS, 2019-2025
12 companies · $752 in 2025
The $752 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2021: $222 · 2024: $36.23 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $384.36 | 2019-2025 | Apligraf, Puraply Wound Matrix, Affinity |
| Medtronic, INC. | $217.88 | 2025 | Inceptiv, Intellis Adaptivestim |
| Kerecis Limited | $183.87 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $135.47 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $70.06 | 2025 | |
| Melinta Therapeutics, LLC | $38.49 | 2021 | |
| Mallinckrodt Hospital Products INC. | $36.23 | 2024 | Acthar |
| Solventum Corporation | $23.78 | 2025 | Prevena |
| Stryker Corporation | $19.97 | 2021 | |
| Ani Pharmaceuticals, INC. | $14.15 | 2025 | Purified Cortrophin Gel |
| Abbvie INC. | $12.28 | 2021 | |
| Smith+Nephew, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.